Literature DB >> 32558952

The determination of β-agonist residues in bovine tissues using liquid chromatography-tandem mass spectrometry.

Yeliz Yikilmaz1, Ozgur Kuzukiran2, Ekrem Erdogan1, Filiz Sen1, Ozlem Kirmizibayrak1, Ayhan Filazi3.   

Abstract

We aimed to develop a rapid, simple and reproducible method based on LC-tandem mass spectrometry (LC-MS/MS) to analyze β-agonist residues (clenbuterol, zilpaterol, ractopamine and isoxsuprine) in bovine tissues. The method was validated in accordance with the European Council Decision 2002/657/EC. The samples were homogenized, and then 10 mL of an acetate buffer was added to a 5-g sample. The sample was then centrifuged at 12,000 rpm and filtered. Sodium hydroxide (2 m) was added to adjust pH of the sample that was centrifuged again. The extract was filtered through a solid-phase extraction column. The residue was re-dissolved in 250 μL acetonitrile and then subjected to LC-MS/MS. The separation was done on a C18 column. The mobile phase consisted of 0.1% formic acid in deionized water and 0.1% formic acid in methanol. The mean recoveries of β-agonists were in the range of 84.3%-119.1% with relative standard deviations (%RSDs) of 0.683%-4.05%. Decision limits and detection capabilities of the analytes ranged from 0.0960 to 4.9349 μg/kg and from 0.0983 to 5.0715, respectively. This method was used to detect four β-agonists in 100 bovine muscle, 100 liver and 100 kidney tissues from a slaughterhouse. No residue was found above the maximum residue limit level.
© 2020 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Beta-agonist; LC-MS/MS; kidney; liver; muscle

Mesh:

Substances:

Year:  2020        PMID: 32558952     DOI: 10.1002/bmc.4926

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  1 in total

1.  Analysis of β-agonists in Different Biological Matrices By Liquid Chromatography-tandem Mass Spectrometry.

Authors:  Tomasz Śniegocki; Bartosz Sell; Andrzej Posyniak
Journal:  J Vet Res       Date:  2021-11-20       Impact factor: 1.744

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.